title: Heparanase induces tissue factor expression in vascular endothelial and cancer cells.
abstract: BACKGROUND
  Over-expression of tissue factor (TF) and activation of the coagulation system are common in cancer patients. Heparanase is an endo-beta-D-glucuronidase that cleaves heparan sulfate chains on cell surfaces and in the extracellular matrix, activity that closely correlates with cell invasion, angiogenesis and tumor metastasis. The study was undertaken to investigate the involvement of heparanase in TF expression.
  
  
  METHODS
  Tumor-derived cell lines were transfected with heparanase cDNA and TF expression was examined. The effect of exogenous addition of active and inactive heparanase on TF expression and activity was studied in tumor cell lines and primary human umbilical vein endothelial cells. TF expression was also explored in heparanase over-expressing transgenic (Tg) mice. Blast cells were collected from acute leukemia patients and TF and heparanase expression levels were analyzed.
  
  
  RESULTS
  Over-expression of heparanase in tumor-derived cell lines resulted in a 2-fold increase in TF expression levels, and a similar trend was observed in heparanase Tg mice in vivo. Likewise, exogenous addition of heparanase to endothelial or tumor-derived cells resulted in enhanced TF expression and activity. Interestingly, TF expression was also induced in response to enzymatically inactive heparanase, suggesting that this effect was independent of heparanase enzymatic activity. The regulatory effect of heparanase on TF expression involved activation of the p38 signaling pathway. A positive correlation between TF expression levels and heparanase activity was found in blasts collected from 22 acute leukemia patients.
  
  
  CONCLUSIONS
  Our results indicate that in addition to its well-known function as an enzyme paving a way for invading cells, heparanase also participates in the regulation of TF gene expression and its related coagulation pathways.
authors.affiliation: Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
authors.forename: Y
authors.initials: Y
authors.lastname: Nadir
authors.forename: B
authors.initials: B
authors.lastname: Brenner
authors.forename: A
authors.initials: A
authors.lastname: Zetser
authors.forename: N
authors.initials: N
authors.lastname: Ilan
authors.forename: I
authors.initials: I
authors.lastname: Shafat
authors.forename: E
authors.initials: E
authors.lastname: Zcharia
authors.forename: O
authors.initials: O
authors.lastname: Goldshmidt
authors.forename: I
authors.initials: I
authors.lastname: Vlodavsky
mesh_terms: D001777:Blood Coagulation / Q000235:genetics; D045744:Cell Line, Tumor; D042783:Endothelial Cells / Q000378:metabolism* / Q000473:pathology; D015973:Gene Expression Regulation, Leukemic / Q000235:genetics; D019763:Heparin Lyase / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000235:genetics; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D013925:Thromboplastin / Q000096:biosynthesis*
chemical_list: D013925:Thromboplastin; D019763:Heparin Lyase